|
EA201391373A1
(ru)
|
2011-03-23 |
2014-07-30 |
Пайонир Хай-Бред Интернэшнл, Инк. |
Способы получения сложного локуса трансгенных признаков
|
|
US10323236B2
(en)
|
2011-07-22 |
2019-06-18 |
President And Fellows Of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
|
AU2014228981B2
(en)
|
2013-03-15 |
2019-11-28 |
The General Hospital Corporation |
Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing
|
|
US10760064B2
(en)
|
2013-03-15 |
2020-09-01 |
The General Hospital Corporation |
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
|
|
SI2986729T1
(sl)
|
2013-04-16 |
2019-02-28 |
Regeneron Pharmaceuticals, Inc. |
Ciljana sprememba genoma podgane
|
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
|
US20160201072A1
(en)
|
2013-08-22 |
2016-07-14 |
Pioneer Hi-Bred International, Inc. |
Genome modification using guide polynucleotide/cas endonuclease systems and methods of use
|
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
|
US9340799B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
MRNA-sensing switchable gRNAs
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
CN110951779B
(zh)
|
2013-12-11 |
2024-04-16 |
瑞泽恩制药公司 |
用于靶向修饰基因组的方法和组合物
|
|
US11053481B2
(en)
|
2013-12-12 |
2021-07-06 |
President And Fellows Of Harvard College |
Fusions of Cas9 domains and nucleic acid-editing domains
|
|
EP4079847A1
(en)
|
2014-07-30 |
2022-10-26 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
|
BR112017003757A2
(pt)
|
2014-09-12 |
2017-12-26 |
Du Pont |
?plantas de milho, partes de planta de milho ou sementes de milho?
|
|
EP3204496A1
(en)
|
2014-10-10 |
2017-08-16 |
Editas Medicine, Inc. |
Compositions and methods for promoting homology directed repair
|
|
GB201418965D0
(enExample)
|
2014-10-24 |
2014-12-10 |
Ospedale San Raffaele And Fond Telethon |
|
|
WO2016073990A2
(en)
|
2014-11-07 |
2016-05-12 |
Editas Medicine, Inc. |
Methods for improving crispr/cas-mediated genome-editing
|
|
US9650617B2
(en)
|
2015-01-28 |
2017-05-16 |
Pioneer Hi-Bred International. Inc. |
CRISPR hybrid DNA/RNA polynucleotides and methods of use
|
|
EP3553178A1
(en)
|
2015-03-27 |
2019-10-16 |
E. I. du Pont de Nemours and Company |
Soybean u6 small nuclear rna gene promoters and their use in constitutive expression of small rna genes in plants
|
|
JP7030522B2
(ja)
|
2015-05-11 |
2022-03-07 |
エディタス・メディシン、インコーポレイテッド |
幹細胞における遺伝子編集のための最適化ｃｒｉｓｐｒ／ｃａｓ９システムおよび方法
|
|
JP7396783B2
(ja)
|
2015-06-09 |
2023-12-12 |
エディタス・メディシン、インコーポレイテッド |
移植を改善するためのｃｒｉｓｐｒ／ｃａｓ関連方法および組成物
|
|
US20160362667A1
(en)
*
|
2015-06-10 |
2016-12-15 |
Caribou Biosciences, Inc. |
CRISPR-Cas Compositions and Methods
|
|
US10648020B2
(en)
|
2015-06-18 |
2020-05-12 |
The Broad Institute, Inc. |
CRISPR enzymes and systems
|
|
US9790490B2
(en)
*
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
|
US11279928B2
(en)
|
2015-06-29 |
2022-03-22 |
Massachusetts Institute Of Technology |
Compositions comprising nucleic acids and methods of using the same
|
|
CA2990699A1
(en)
|
2015-06-29 |
2017-01-05 |
Ionis Pharmaceuticals, Inc. |
Modified crispr rna and modified single crispr rna and uses thereof
|
|
US9926546B2
(en)
|
2015-08-28 |
2018-03-27 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
US9512446B1
(en)
|
2015-08-28 |
2016-12-06 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
AU2016326711B2
(en)
|
2015-09-24 |
2022-11-03 |
Editas Medicine, Inc. |
Use of exonucleases to improve CRISPR/Cas-mediated genome editing
|
|
IL294014B2
(en)
|
2015-10-23 |
2024-07-01 |
Harvard College |
Nucleobase editors and uses thereof
|
|
ES2699848T3
(es)
|
2015-10-23 |
2019-02-13 |
Caribou Biosciences Inc |
Acido nucleico CRISPR clase 2 de tipo cruzado modificado que se dirige a ácidos nucleicos
|
|
JP6707133B2
(ja)
*
|
2015-12-04 |
2020-06-10 |
カリブー・バイオサイエンシーズ・インコーポレイテッド |
操作された核酸標的化核酸
|
|
US9988624B2
(en)
|
2015-12-07 |
2018-06-05 |
Zymergen Inc. |
Microbial strain improvement by a HTP genomic engineering platform
|
|
US11208649B2
(en)
|
2015-12-07 |
2021-12-28 |
Zymergen Inc. |
HTP genomic engineering platform
|
|
CN109310784B
(zh)
|
2015-12-07 |
2022-08-19 |
阿克生物公司 |
用于制备和使用指导核酸的方法和组合物
|
|
BR112018011503A2
(pt)
|
2015-12-07 |
2018-12-04 |
Zymergen Inc |
promotores da corynebacterium glutamicum
|
|
WO2017136794A1
(en)
|
2016-02-03 |
2017-08-10 |
Massachusetts Institute Of Technology |
Structure-guided chemical modification of guide rna and its applications
|
|
US9896696B2
(en)
|
2016-02-15 |
2018-02-20 |
Benson Hill Biosystems, Inc. |
Compositions and methods for modifying genomes
|
|
EP3433363A1
(en)
|
2016-03-25 |
2019-01-30 |
Editas Medicine, Inc. |
Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
|
|
WO2017180694A1
(en)
|
2016-04-13 |
2017-10-19 |
Editas Medicine, Inc. |
Cas9 fusion molecules gene editing systems, and methods of use thereof
|
|
KR102670601B1
(ko)
|
2016-04-19 |
2024-05-29 |
더 브로드 인스티튜트, 인코퍼레이티드 |
신규한 crispr 효소 및 시스템
|
|
CN106244591A
(zh)
*
|
2016-08-23 |
2016-12-21 |
苏州吉玛基因股份有限公司 |
修饰crRNA在CRISPR/Cpf1基因编辑系统中的应用
|
|
CN109642232A
(zh)
|
2016-06-01 |
2019-04-16 |
Kws种子欧洲股份公司 |
用于基因组改造的杂合核酸序列
|
|
US10767175B2
(en)
|
2016-06-08 |
2020-09-08 |
Agilent Technologies, Inc. |
High specificity genome editing using chemically modified guide RNAs
|
|
KR102345898B1
(ko)
|
2016-06-30 |
2022-01-03 |
지머젠 인코포레이티드 |
글루코오스 투과 효소 라이브러리를 생성하는 방법 및 이의 용도
|
|
KR102345899B1
(ko)
|
2016-06-30 |
2021-12-31 |
지머젠 인코포레이티드 |
박테리아 헤모글로빈 라이브러리를 생성하는 방법 및 이의 용도
|
|
US11845929B2
(en)
*
|
2016-07-08 |
2023-12-19 |
Ohio State Innovation Foundation |
Modified nucleic acids, hybrid guide RNAs, and uses thereof
|
|
WO2018027078A1
(en)
|
2016-08-03 |
2018-02-08 |
President And Fellows Of Harard College |
Adenosine nucleobase editors and uses thereof
|
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
|
US20190264193A1
(en)
|
2016-08-12 |
2019-08-29 |
Caribou Biosciences, Inc. |
Protein engineering methods
|
|
SG11201901306XA
(en)
*
|
2016-08-19 |
2019-03-28 |
Toolgen Inc |
Artificially engineered angiogenesis regulatory system
|
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
US11306305B2
(en)
|
2016-09-23 |
2022-04-19 |
Board Of Trustees Of Southern Illinois University |
Tuning CRISPR/Cas9 activity with chemically modified nucleotide substitutions
|
|
US11242542B2
(en)
|
2016-10-07 |
2022-02-08 |
Integrated Dna Technologies, Inc. |
S. pyogenes Cas9 mutant genes and polypeptides encoded by same
|
|
CN118726313A
(zh)
|
2016-10-07 |
2024-10-01 |
综合Dna技术公司 |
化脓链球菌cas9突变基因和由其编码的多肽
|
|
SG11201903089RA
(en)
|
2016-10-14 |
2019-05-30 |
Harvard College |
Aav delivery of nucleobase editors
|
|
US20180282722A1
(en)
*
|
2016-11-21 |
2018-10-04 |
Massachusetts Institute Of Technology |
Chimeric DNA:RNA Guide for High Accuracy Cas9 Genome Editing
|
|
WO2018098383A1
(en)
|
2016-11-22 |
2018-05-31 |
Integrated Dna Technologies, Inc. |
Crispr/cpf1 systems and methods
|
|
US9816093B1
(en)
|
2016-12-06 |
2017-11-14 |
Caribou Biosciences, Inc. |
Engineered nucleic acid-targeting nucleic acids
|
|
US11293022B2
(en)
|
2016-12-12 |
2022-04-05 |
Integrated Dna Technologies, Inc. |
Genome editing enhancement
|
|
WO2018119010A1
(en)
|
2016-12-19 |
2018-06-28 |
Editas Medicine, Inc. |
Assessing nuclease cleavage
|
|
US10745677B2
(en)
|
2016-12-23 |
2020-08-18 |
President And Fellows Of Harvard College |
Editing of CCR5 receptor gene to protect against HIV infection
|
|
JP2020503017A
(ja)
*
|
2016-12-28 |
2020-01-30 |
アイオーニス ファーマシューティカルズ， インコーポレーテッドＩｏｎｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
修飾ｃｒｉｓｐｒ ｒｎａ及びその使用
|
|
EP4095263A1
(en)
|
2017-01-06 |
2022-11-30 |
Editas Medicine, Inc. |
Methods of assessing nuclease cleavage
|
|
DK3574101T5
(da)
*
|
2017-01-30 |
2024-09-02 |
Kws Saat Se & Co Kgaa |
Reparationsskabelonbinding til endonukleaser til genommodifikation
|
|
EP3592853A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Suppression of pain by gene editing
|
|
EP3592381A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Cancer vaccine
|
|
CN110914310A
(zh)
|
2017-03-10 |
2020-03-24 |
哈佛大学的校长及成员们 |
胞嘧啶至鸟嘌呤碱基编辑器
|
|
GB2575930A
(en)
|
2017-03-23 |
2020-01-29 |
Harvard College |
Nucleobase editors comprising nucleic acid programmable DNA binding proteins
|
|
WO2018183403A1
(en)
|
2017-03-28 |
2018-10-04 |
Caribou Biosciences, Inc. |
Crispr-associated (cas) protein
|
|
WO2018201086A1
(en)
|
2017-04-28 |
2018-11-01 |
Editas Medicine, Inc. |
Methods and systems for analyzing guide rna molecules
|
|
WO2018209320A1
(en)
|
2017-05-12 |
2018-11-15 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
|
|
CN108977442B
(zh)
*
|
2017-06-05 |
2023-01-06 |
广州市锐博生物科技有限公司 |
用于dna编辑的系统及其应用
|
|
CA3102054A1
(en)
|
2017-06-05 |
2018-12-13 |
Fred Hutchinson Cancer Research Center |
Genomic safe harbors for genetic therapies in human stem cells and engineered nanoparticles to provide targeted genetic therapies
|
|
CA3061984A1
(en)
|
2017-06-06 |
2018-12-13 |
Zymergen Inc. |
A htp genomic engineering platform for improving fungal strains
|
|
KR20200026874A
(ko)
|
2017-06-06 |
2020-03-11 |
지머젠 인코포레이티드 |
대장균 개량을 위한 htp 게놈 공학 플랫폼
|
|
CN111094565B
(zh)
*
|
2017-06-07 |
2024-02-06 |
阿克生物公司 |
指导核酸的产生和用途
|
|
AU2018279829B2
(en)
|
2017-06-09 |
2024-01-04 |
Editas Medicine, Inc. |
Engineered Cas9 nucleases
|
|
EP3638792A1
(en)
|
2017-06-14 |
2020-04-22 |
Wisconsin Alumni Research Foundation |
Modified guide rnas, crispr-ribonucleotprotein complexes and methods of use
|
|
WO2019014564A1
(en)
|
2017-07-14 |
2019-01-17 |
Editas Medicine, Inc. |
SYSTEMS AND METHODS OF TARGETED INTEGRATION AND GENOME EDITING AND DETECTION THEREOF WITH INTEGRATED PRIMING SITES
|
|
CN112501254B
(zh)
|
2017-07-14 |
2024-07-19 |
上海吐露港生物科技有限公司 |
一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒
|
|
US11584955B2
(en)
*
|
2017-07-14 |
2023-02-21 |
Shanghai Tolo Biotechnology Company Limited |
Application of Cas protein, method for detecting target nucleic acid molecule and kit
|
|
US11732274B2
(en)
|
2017-07-28 |
2023-08-22 |
President And Fellows Of Harvard College |
Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
|
|
EP4407034A3
(en)
|
2017-08-09 |
2024-10-30 |
RiceTec, Inc. |
Compositions and methods for modifying genomes
|
|
EP3676376B1
(en)
|
2017-08-30 |
2025-01-15 |
President and Fellows of Harvard College |
High efficiency base editors comprising gam
|
|
EP3676378A4
(en)
|
2017-08-31 |
2021-06-09 |
The New York Genome Center |
PROCEDURES AND COMPOSITIONS USING CRIMP-CPF1 AND PAIRED GUIDE-CRISPR-RNA FOR PROGRAMMABLE GENOMIC DELETIONS
|
|
WO2019079347A1
(en)
|
2017-10-16 |
2019-04-25 |
The Broad Institute, Inc. |
USES OF BASIC EDITORS ADENOSINE
|
|
CN111448313A
(zh)
|
2017-11-16 |
2020-07-24 |
阿斯利康(瑞典)有限公司 |
用于改善基于Cas9的敲入策略的有效性的组合物和方法
|
|
US20210002609A1
(en)
|
2017-12-05 |
2021-01-07 |
Caribou Biosciences, Inc. |
Modified lymphocytes
|
|
WO2019118949A1
(en)
|
2017-12-15 |
2019-06-20 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
WO2019118893A1
(en)
|
2017-12-15 |
2019-06-20 |
Dana-Farber Cancer Institute, Inc. |
Stabilized peptide-mediated targeted protein degradation
|
|
WO2019147743A1
(en)
*
|
2018-01-26 |
2019-08-01 |
Massachusetts Institute Of Technology |
Structure-guided chemical modification of guide rna and its applications
|
|
US20210093679A1
(en)
|
2018-02-05 |
2021-04-01 |
Novome Biotechnologies, Inc. |
Engineered gut microbes and uses thereof
|
|
US20220010293A1
(en)
|
2018-02-23 |
2022-01-13 |
Pioneer Hi-Bred International, Inc. |
Novel cas9 orthologs
|
|
WO2019173248A1
(en)
|
2018-03-07 |
2019-09-12 |
Caribou Biosciences, Inc. |
Engineered nucleic acid-targeting nucleic acids
|
|
KR20210003819A
(ko)
|
2018-04-19 |
2021-01-12 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
유전자 편집을 위한 조성물 및 방법
|
|
EP3794130A4
(en)
|
2018-05-16 |
2022-07-27 |
Synthego Corporation |
METHODS AND SYSTEMS FOR DESIGNING AND USING GUIDE RNA
|
|
WO2019226953A1
(en)
|
2018-05-23 |
2019-11-28 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
US12227776B2
(en)
|
2018-06-13 |
2025-02-18 |
Caribou Biosciences, Inc. |
Engineered cascade components and cascade complexes
|
|
US10227576B1
(en)
|
2018-06-13 |
2019-03-12 |
Caribou Biosciences, Inc. |
Engineered cascade components and cascade complexes
|
|
IL278106B2
(en)
*
|
2018-06-13 |
2025-02-01 |
Caribou Biosciences Inc |
Engineered CASCADE Components and CASCADE Complexes
|
|
AU2019291918B2
(en)
|
2018-06-29 |
2025-06-12 |
Editas Medicine, Inc. |
Synthetic guide molecules, compositions and methods relating thereto
|
|
WO2020049158A1
(en)
|
2018-09-07 |
2020-03-12 |
Astrazeneca Ab |
Compositions and methods for improved nucleases
|
|
ES2927220T3
(es)
|
2018-10-01 |
2022-11-03 |
Caribou Biosciences Inc |
Composiciones y procedimientos de módulos suicidas
|
|
KR102126573B1
(ko)
|
2018-10-18 |
2020-06-26 |
대한민국 |
CRISPR-Cas9 시스템을 이용한 유색고약버섯의 리그닌 분해효소의 유전자 편집방법 및 이의 용도
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
EP3874037A4
(en)
*
|
2018-10-31 |
2021-12-15 |
Zymergen, Inc. |
DETERMINIST MULTIPLEXED SET OF DNA LIBRARIES
|
|
US11739320B2
(en)
|
2018-11-05 |
2023-08-29 |
Wisconsin Alumni Research Foundation |
Gene correction of Pompe disease and other autosomal recessive disorders via RNA-guided nucleases
|
|
CN113166744B
(zh)
|
2018-12-14 |
2025-02-07 |
先锋国际良种公司 |
用于基因组编辑的新颖crispr-cas系统
|
|
US12351837B2
(en)
|
2019-01-23 |
2025-07-08 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
AU2020210884A1
(en)
*
|
2019-01-25 |
2021-08-12 |
Synthego Corporation |
Systems and methods for modulating CRISPR activity
|
|
WO2020176389A1
(en)
|
2019-02-25 |
2020-09-03 |
Caribou Biosciences, Inc. |
Plasmids for gene editing
|
|
KR20210136997A
(ko)
|
2019-03-08 |
2021-11-17 |
지머젠 인코포레이티드 |
미생물에서 반복적 게놈 편집
|
|
US11053515B2
(en)
|
2019-03-08 |
2021-07-06 |
Zymergen Inc. |
Pooled genome editing in microbes
|
|
DE112020001342T5
(de)
|
2019-03-19 |
2022-01-13 |
President and Fellows of Harvard College |
Verfahren und Zusammensetzungen zum Editing von Nukleotidsequenzen
|
|
US10982187B2
(en)
|
2019-03-26 |
2021-04-20 |
Genus Plc |
Bos taurus variety ‘HO840003150607238’ and methods of use thereof
|
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
US10975351B2
(en)
|
2019-06-17 |
2021-04-13 |
Abs Global, Inc. |
Bos taurus variety ‘JE840003146074527’ and methods of use therof
|
|
MX2022002642A
(es)
*
|
2019-09-05 |
2022-06-14 |
Benson Hill Inc |
Composiciones y metodos para modificar genomas.
|
|
WO2021072328A1
(en)
|
2019-10-10 |
2021-04-15 |
The Broad Institute, Inc. |
Methods and compositions for prime editing rna
|
|
WO2021099996A1
(en)
|
2019-11-19 |
2021-05-27 |
Benson Hill, Inc. |
Anti-bacterial crispr compositions and methods
|
|
EP4438729A3
(en)
|
2019-12-09 |
2025-03-26 |
Caribou Biosciences, Inc. |
Crispr abasic restricted nucleotides and crispr accuracy via analogs
|
|
CA3166430A1
(en)
*
|
2020-02-05 |
2021-08-12 |
Ryan T. Gill |
Compositions and methods for targeting, editing or modifying human genes
|
|
WO2021173734A1
(en)
*
|
2020-02-24 |
2021-09-02 |
The Broad Institute, Inc. |
Novel type iv and type i crispr-cas systems and methods of use thereof
|
|
WO2021204877A2
(en)
|
2020-04-08 |
2021-10-14 |
Astrazeneca Ab |
Compositions and methods for improved site-specific modification
|
|
GB2614813B
(en)
|
2020-05-08 |
2025-05-07 |
Harvard College |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
|
EP4150091A4
(en)
*
|
2020-05-12 |
2025-07-23 |
Univ Massachusetts |
MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING
|
|
CA3198905A1
(en)
*
|
2020-10-19 |
2022-04-28 |
Caribou Biosciences, Inc. |
Dna-containing polynucleotides and guides for crispr type v systems, and methods of making and using the same
|
|
CN112301162B
(zh)
*
|
2020-10-22 |
2023-09-22 |
清华-伯克利深圳学院筹备办公室 |
同时检测dna病毒和rna病毒的病毒核酸检测方法
|
|
US20240182890A1
(en)
|
2021-04-07 |
2024-06-06 |
Astrazeneca Ab |
Compositions and methods for site-specific modification
|
|
IL311607A
(en)
*
|
2021-09-22 |
2024-05-01 |
Verve Therapeutics Inc |
Gene editing of pcsk9 or angptl3 and compositions and methods of using same for treatment of disease
|
|
EP4408996A2
(en)
|
2021-09-30 |
2024-08-07 |
Astrazeneca AB |
Use of inhibitors to increase efficiency of crispr/cas insertions
|
|
CN117999481A
(zh)
|
2021-10-26 |
2024-05-07 |
卡里布生物科学公司 |
核酸外切酶偶联实时核酸内切酶活性测定
|
|
US12416045B2
(en)
*
|
2021-12-07 |
2025-09-16 |
Caribou Biosciences, Inc. |
Method of capturing CRISPR endonuclease cleavage products
|
|
WO2023185697A2
(en)
*
|
2022-03-29 |
2023-10-05 |
Accuredit Therapeutics (Suzhou) Co., Ltd. |
Compositions and methods for treatment of transthyretin amyloidosis
|
|
US20250325698A1
(en)
*
|
2022-04-13 |
2025-10-23 |
Caribou Biosciences, Inc. |
Therapeutic applications of crispr type v systems
|
|
WO2023224327A1
(ko)
*
|
2022-05-20 |
2023-11-23 |
한국생명공학연구원 |
오토라이신을 활용한 미세조류의 유전자 교정 효율을 증대시키기 위한 시스템 및 방법
|
|
WO2023230529A1
(en)
|
2022-05-26 |
2023-11-30 |
Caribou Biosciences, Inc. |
Cytokine-receptor fusions for immune cell stimulation
|
|
AU2023285071B2
(en)
|
2022-06-06 |
2025-02-20 |
Caribou Biosciences, Inc. |
Treatment of autoimmune diseases with engineered immune cells
|
|
WO2024041653A1
(zh)
|
2022-08-26 |
2024-02-29 |
广州瑞风生物科技有限公司 |
一种CRISPR-Cas13系统及其应用
|
|
AU2023353989A1
(en)
|
2022-09-30 |
2025-02-27 |
Caribou Biosciences, Inc. |
Anti-ror1 chimeric antigen receptors (cars), cells expressing the cars and related methods
|
|
KR20250068756A
(ko)
|
2022-11-14 |
2025-05-16 |
카리부 바이오사이언시스 인코포레이티드 |
항-cll-1 키메라 항원 수용체, 조작된 세포 및 관련 방법
|
|
EP4414452A1
(en)
*
|
2023-02-13 |
2024-08-14 |
Universidad de Granada |
Dual-guide rna composition for executing a single-guide rna crispr-associated system
|
|
WO2024201368A1
(en)
|
2023-03-29 |
2024-10-03 |
Astrazeneca Ab |
Use of inhibitors to increase efficiency of crispr/cas insertions
|
|
KR20250152085A
(ko)
|
2023-05-01 |
2025-10-22 |
카리부 바이오사이언시스 인코포레이티드 |
Bcma-표적화 조작된 면역 세포를 이용한 자가면역 질환의 치료
|
|
AU2024270764A1
(en)
|
2023-05-15 |
2025-12-04 |
Nchroma Bio, Inc. |
Compositions and methods for epigenetic regulation of hbv gene expression
|
|
WO2025006880A1
(en)
|
2023-06-29 |
2025-01-02 |
Caribou Biosciences, Inc. |
Diagnostic and therapeutic methods for use with ror1 antagonists
|
|
WO2025024676A1
(en)
|
2023-07-26 |
2025-01-30 |
Caribou Biosciences, Inc. |
In vitro validation methods for cd19-targeting cell therapies
|
|
CN119614679A
(zh)
*
|
2023-09-14 |
2025-03-14 |
厦门大学 |
一款通用型核酸检测平台
|
|
WO2025064930A1
(en)
*
|
2023-09-20 |
2025-03-27 |
Emory University |
Nucleic acid hairpin based triggered hydrogels and uses thereof
|
|
WO2025117745A1
(en)
|
2023-12-01 |
2025-06-05 |
Caribou Biosciences, Inc. |
Methods and compositions for improving precision of endonuclease-mediated genome editing
|
|
WO2025193609A1
(en)
|
2024-03-11 |
2025-09-18 |
Caribou Biosciences, Inc. |
Methods and compositions for cost-effective assessment of nucleic acid transcripts and isoforms in cells
|
|
WO2025193386A1
(en)
|
2024-03-13 |
2025-09-18 |
Caribou Biosciences, Inc. |
Treatment regimens for autoimmune disease with cd19-targeting engineered immune cells
|